Adeno-Associated Virus Antibody Profiles in Newborns, Children, and Adolescents

被引:262
作者
Calcedo, Roberto [1 ]
Morizono, Hiroki [2 ]
Wang, Lili [1 ]
McCarter, Robert [3 ]
He, Jianping [3 ]
Jones, David [2 ]
Batshaw, Mark L. [2 ]
Wilson, James M. [1 ]
机构
[1] Univ Penn, Dept Pathol & Lab Med, Gene Therapy Program, Philadelphia, PA 19104 USA
[2] Childrens Natl Med Ctr, Med Genet Res Ctr, Childrens Res Inst, Washington, DC 20010 USA
[3] Childrens Natl Med Ctr, Ctr Clin & Community Res, Childrens Res Inst, Washington, DC 20010 USA
关键词
HUMAN GENE-THERAPY; VIRAL VECTORS; T-CELLS; SEROTYPE-2; LIVER; TRANSDUCTION; EXPRESSION; MICE;
D O I
10.1128/CVI.05107-11
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Neutralizing antibodies (NAb) to an adeno-associated virus (AAV) vector due to previous natural infection with wild-type AAV can significantly limit gene transfer. NAb titers to AAV serotype 2 (AAV2) and AAV8 in human subjects (0 to 18 years) were studied. NAb prevalence is moderate at birth, decreases markedly from 7 to 11 months, and then progressively increases through childhood and adolescence.
引用
收藏
页码:1586 / 1588
页数:3
相关论文
共 19 条
[1]   Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors [J].
Boutin, Sylvie ;
Monteilhet, Virginie ;
Veron, Philippe ;
Leborgne, Christian ;
Benveniste, Olivier ;
Montus, Marie Francoise ;
Masurier, Carole .
HUMAN GENE THERAPY, 2010, 21 (06) :704-712
[2]   Evidence for infection of the human embryo with adeno-associated virus in pregnancy [J].
Burguete, T ;
Rabreau, M ;
Fontanges-Darriet, M ;
Roset, E ;
Hager, HD ;
Köppel, A ;
Bischof, P ;
Schlehofer, JR .
HUMAN REPRODUCTION, 1999, 14 (09) :2396-2401
[3]   Worldwide Epidemiology of Neutralizing Antibodies to Adeno-Associated Viruses [J].
Calcedo, Roberto ;
Vandenberghe, Luk H. ;
Gao, Guangping ;
Lin, Jianping ;
Wilson, James M. .
JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (03) :381-390
[4]   Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models [J].
Davidoff, AM ;
Gray, JT ;
Ng, CYC ;
Zhang, YB ;
Zhou, JF ;
Spence, Y ;
Bakar, Y ;
Nathwani, AC .
MOLECULAR THERAPY, 2005, 11 (06) :875-888
[5]   Detection of adeno-associated virus type 2 sequences in the human genital tract [J].
FriedmanEinat, M ;
Grossman, Z ;
Mileguir, F ;
Smetana, Z ;
Ashkenazi, M ;
Barkai, G ;
Varsano, N ;
Glick, E ;
Mendelson, E .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (01) :71-78
[6]   Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy [J].
Gao, GP ;
Alvira, MR ;
Wang, LL ;
Calcedo, R ;
Johnston, J ;
Wilson, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11854-11859
[7]   Preexisting Immunity and Low Expression in Primates Highlight Translational Challenges for Liver-directed AAV8-mediated Gene Therapy [J].
Hurlbut, Gregory D. ;
Ziegler, Robin J. ;
Nietupski, Jennifer B. ;
Foley, Joseph W. ;
Woodworth, Lisa A. ;
Meyers, Elizabeth ;
Bercury, Scott D. ;
Pande, Nilesh N. ;
Souza, David W. ;
Bree, Mark P. ;
Lukason, Michael J. ;
Marshall, John ;
Cheng, Seng H. ;
Scheule, Ronald K. .
MOLECULAR THERAPY, 2010, 18 (11) :1983-1994
[8]   Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy [J].
Jiang, Haiyan ;
Couto, Linda B. ;
Patarroyo-White, Susannah ;
Liu, Tongyao ;
Nagy, Dea ;
Vargas, Joseph A. ;
Zhou, Shangzhen ;
Scallan, Ciaran D. ;
Sommer, Jurg ;
Vijay, Sharmila ;
Mingozzi, Federico ;
High, Katherine A. ;
Pierce, Glenn F. .
BLOOD, 2006, 108 (10) :3321-3328
[9]  
PARKS W P, 1970, Infection and Immunity, V2, P716
[10]  
Parry S, 1998, AM J PATHOL, V152, P1521